UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

 

 

Date of Report: July 24, 2020

(Date of earliest event reported)

 

Intrepid Potash, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware 001-34025 26-1501877

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

 

1001 17th Street, Suite 1050

Denver, Colorado 80202

(Address of principal executive offices and zip code)

 

(303) 296-3006

(Registrant's telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading symbol Name of each exchange on which registered
Common Stock, par value $0.001 per share IPI New York Stock Exchange

 

Indicate by checkmark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)

 

 
Emerging growth company  ¨  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨  

 

 

 

 

 

 

Item 3.01.Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

On July 24, 2020, Intrepid Potash, Inc. (the “Company”) received notice from the New York Stock Exchange (the “NYSE”) that it is no longer in compliance with Section 802.01C of the NYSE Listed Company Manual (“Section 802.01C”) that requires listed companies to maintain an average closing share price of at least $1.00 over a period of 30 consecutive trading days (the “Notice”).

 

Pursuant to Section 802.01C, the Company generally has a period of six months following the receipt of the Notice to regain compliance with the minimum share price requirement, subject to any extensions by NYSE. The Company can regain compliance with the minimum share price requirement at any time during the cure period if, on the last trading day of any calendar month during the cure period or on the last day of the cure period, the Company has a closing share price of at least $1.00 per share and an average closing share price of at least $1.00 per share over the 30 trading-day period ending on such date. As required by the NYSE, the Company intends to notify the NYSE within 10 business days of receipt of the Notice of its intent to cure the listing standard deficiency and regain compliance with the minimum share price requirement.

 

As disclosed in Item 5.07 below, the Company held the Special Meeting (as defined below) to approve four proposals related to a potential reverse split of the Company’s stock and subsequent reductions in the number of authorized shares of the Company’s common stock. The Company’s stockholders voted to approve all proposals presented, which together grant the Company’s Board of Directors (the “Board”) authority to effect a reverse stock split of its the Company’s shares of common stock at a ratio not less than 1-for-3 and not greater than 1-for-15 and, conditional on the split, to effect a corresponding reduction in the number of authorized common shares of common stock according to the criteria outlined in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on June 30, 2020. In addition to a reverse split of common stock, the Company intends to consider all available options to cure the deficiency and restore compliance. The Company is in compliance with all other NYSE continued listing standard rules.

 

The Notice does not affect ongoing business operations of the Company or its reporting requirements with the Securities and Exchange Commission. nor does it trigger any violation of the Company’s material debt obligations. The Notice also has no immediate impact on the listing of the Company’s common stock, which will continue to be listed and traded on the NYSE during the cure period under the symbol “IPI” but will have an added designation of “.BC” to indicate the status of the common stock as below compliance. If the Company fails to regain compliance with Section 802.01C during the cure period, the Company’s common stock will be subject to the NYSE’s suspension and delisting procedures.

 

Item 5.07.Submission of Matters to a Vote of Security Holders.

 

On July 28, 2020, the Company held a special meeting of its stockholders (the “Special Meeting”) as a virtual meeting online via live audio webcast. As of the record date for the Special Meeting, there were 132,951,858 shares of the Company’s common stock outstanding. The holders of 118,486,241 shares were represented in person or by proxy at the Special Meeting. The Company’s stockholders voted on, and approved, the following proposal at the Special Meeting:

 

Proposal 1.      To approve an amendment to the Company’s Restated Certificate of Incorporation to effect a reverse stock split, or the “Reverse Stock Split,” of the Company’s common stock at a ratio using a whole number ranging from one-for-three (1:3) to one-for-fifteen (1:15), with the exact ratio and effective time as may be determined at a later date by the Company’s Board of Directors in its sole discretion.

 

Votes For   Votes Against   Abstentions  
113,015,625   5,308,518   162,098  

 

Proposal 2.      Approval of an amendment to the Company’s Restated Certificate of Incorporation to effect, if and only if Proposal 1 is both approved and implemented, a reduction in the total number of authorized shares of the Company’s common stock to 80,000,000.

 

Votes For   Votes Against   Abstentions  
112,815,687   4,525,315   1,145,239  

 

Proposal 3.      Approval of an amendment to the Company’s Restated Certificate of Incorporation to effect, if and only if Proposal 1 is both approved and implemented, a reduction in the total number of authorized shares of the Company’s common stock to 40,000,000.

 

Votes For   Votes Against   Abstentions  
112,348,893   4,684,960   1,452,388  

 

 

 

 

Proposal 4.       Approval of an amendment to the Company’s Restated Certificate of Incorporation to effect, if and only if Proposal 1 is both approved and implemented, a reduction in the total number of authorized shares of the Company’s common stock to 26,666,667.

 

Votes For   Votes Against   Abstentions  
112,639,671   4,663,525   1,183,045  

 

Item 7.01Regulation FD Disclosure.

 

On July 30, 2020, the Company issued a press release announcing the receipt of the Notice and the voting results from the Special Meeting. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

The information furnished under this Item 7.01, including Exhibit 99.1, will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 and will not be incorporated by reference into any filing under the Securities Act of 1933, except as expressly set forth by specific reference in that filing.

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibit No.   Description
99.1   Press Release of Intrepid Potash, Inc. dated July 30, 2020.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  INTREPID POTASH, INC.
     
Dated: July 30, 2020 By:   /s/ Matthew D. Preston
    Matthew D. Preston
    Vice President of Finance

 

 

 

 

 

Exhibit 99.1

 

 

Intrepid Potash Announces Stockholder Approval of Reverse Split Proposals and Receipt of NYSE Continued Listing Standard Notice

 

DENVER, CO; July 30, 2020 - Intrepid Potash Inc. (NYSE:IPI) (“Intrepid” or the “Company”) today announced that at the special meeting of stockholders held on July 28, 2020, Intrepid’s stockholders voted to approve all proposals presented, which together grant Intrepid’s Board of Directors (the “Board”) authority to effect a reverse stock split of its shares of common stock at a ratio not less than 1-for-3 and not greater than 1-for-15 and, conditional on the split, to effect a corresponding reduction in the number of authorized common shares according to the criteria outlined in Intrepid’s Definitive Proxy Statement dated June 30, 2020.

 

Intrepid plans to convene its Board to discuss a possible split on August 10, 2020. In accordance with the approved proposals, the exact ratio and effective date of the split, if the Board elects to pursue one, will be set within the approved range at the sole discretion of the Board without further approval or authorization of Intrepid's stockholders.

 

NYSE Continued Listing Standard Notice

 

On July 24, 2020, Intrepid received formal notice of non-compliance with the New York Stock Exchange (“NYSE”) share price continued listing standards, which require a listed common stock to maintain a minimum average closing price of $1.00 per share for 30 consecutive days.

 

Under NYSE rules, Intrepid generally has six months following receipt of the notification to regain compliance with this continued listing standard and avoid delisting, subject to any extensions by NYSE. As required by NYSE rules, the Company will notify the NYSE within 10 business days of its intent to cure the share price deficiency. The Company can regain compliance at any time during the cure period if its common stock has a closing price of at least $1.00 per share on the last trading day of any calendar month during the cure period and an average closing price of at least $1.00 per share of common stock over the 30-trading-day period ending on the last trading day of that month. If both a $1.00 end-of-month trading price and a $1.00 average closing share price over the 30-trading-day period ending on the last day of the month are not achieved on any given month during the cure period, the NYSE will commence suspension and delisting procedures. The Company is in compliance with all other NYSE continued listing standard rules.

 

Subject to its compliance with other continued listing requirements, Intrepid’s common stock will continue to be listed and trade on the NYSE during the cure period outlined above under the symbol “IPI” but will have an added designation of “.BC” to indicate the status of the common stock as below compliance. The current non-compliance with the NYSE listing standards does not affect Intrepid’s ongoing business operations or its U.S. Securities and Exchange Commission reporting requirements, nor does it trigger any violation of the Company’s material debt obligations. In addition to a reverse split of common stock, the Company is considering all other available options to regain compliance with the NYSE’s continued listing standards.

 

1

 

 

About Intrepid:

 

Intrepid is a diversified mineral company that delivers potassium, magnesium, sulfur, salt, and water products essential for customer success in agriculture, animal feed, and the oil and gas industry. Intrepid is the only U.S. producer of muriate of potash, which is applied as an essential nutrient for healthy crop development, utilized in several industrial applications, and used as an ingredient in animal feed. In addition, Intrepid produces a specialty fertilizer, Trio®, which delivers three key nutrients, potassium, magnesium, and sulfate, in a single particle. Intrepid also provides water, magnesium chloride, brine, and various oilfield products and services.

Intrepid serves diverse customers in markets where a logistical advantage exists and is a leader in the use of solar evaporation for potash production, resulting in lower cost and more environmentally friendly production. Intrepid's mineral production comes from three solar solution potash facilities and one conventional underground Trio® mine.

 

Intrepid routinely posts important information, including information about upcoming investor presentations and press releases, on its website under the Investor Relations tab. Investors and other interested parties are encouraged to enroll at intrepidpotash.com, to receive automatic email alerts for new postings.

 

Forward-Looking Statements:

 

This press release includes certain statements concerning expectations for the future that are forward-looking within the meaning of the federal securities laws. Forward-looking statements contain known and unknown risks and uncertainties (many of which are difficult to predict and beyond management's control) that may cause Intrepid’s actual results in future periods to differ materially from anticipated or projected results. Forward-looking statements in this press release include, among others, statements regarding Intrepid’s ability to regain compliance with the NYSE’s continued listing standards and whether any potential reverse stock split of the Company’s shares of common stock and corresponding reduction in the number of authorized shares of common stock will help Intrepid regain compliance with the NYSE’s continued listing standards. An extensive list of specific material risks and uncertainties affecting Intrepid is contained in its Annual Report on Form 10-K for the year ended December 31, 2019, and other quarterly and current reports filed with the Securities and Exchange Commission from time to time. Any forward-looking statements in this press release are made as of the date of this press release, and Intrepid undertakes no obligation to update or revise any forward-looking statements to conform the statements to actual results or to reflect new information or future events.

 

Contact:

Matt Preston, Vice President of Finance

Phone: 303-996-3048

Email: matt.preston@intrepidpotash.com

 

2